Jaguar Animal Health (NASDAQ: JAGX) — Perfil da empresa, notícias e dados financeiros
Jaguar Animal Health develops gastrointestinal products for animals, focusing on improving health across various species.
Jaguar Animal Health
Jaguar Animal Health (NASDAQ:JAGX) is a company focused on developing and commercializing gastrointestinal products for both domestic and wild animals. Pioneering innovative solutions, Jaguar aims to improve animal health management and outcomes across a broad spectrum of species. The company's projects range from prescription and non-prescription medications to biome-based therapies, geared towards addressing significant market needs in the veterinary health sector. Jaguar's primary objective is to enhance the quality of veterinary care through its diverse product portfolio, ensuring animals lead healthier and more comfortable lives. Presently, Jaguar Animal Health trades on the NASDAQ under the ticker symbol JAGX, showcasing its commitment to advancing animal health on a global scale.
Resumo
Operações
Produtos e/ou serviços de Jaguar Animal Health
- Gastrointestinal products for domestic and production animals to improve digestive health and nutrient absorption.
- Canalevia-CA1 for chemotherapy-induced diarrhea in dogs, enhancing their comfort and treatment effectiveness.
- Equilevia, a personalized, premium gut health product for horses, designed to support overall wellness and performance.
- Neonorm Calf, a botanical extract for newborn calves to reduce water loss from scours and improve hydration.
- Herbal extract formulations for animal gastrointestinal health, leveraging traditional knowledge with modern science.
- Collaborative research on novel animal health solutions, focusing on natural and sustainable remedies.
equipe executiva do Jaguar Animal Health
- Lisa A. ConteFounder, CEO, President & Director
- Pravin R. ChaturvediChief Scientific Officer & Chair of Scientific Advisory Board
- Jonathan S. WolinChief of Staff, Chief Compliance Officer & General Counsel
- Steven R. KingChief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary
- Carol R. LizakCFO & Treasurer
- Peter HodgeSenior Director of Investor Relations, Business Development & Special Events
- David SesinChief Manufacturing Officer
- Ian H. WendtChief Business Officer
- Massimo RadaelliPresident of Jaguar International
Últimas notícias sobre a Jaguar Animal Health
Comunicados recentes
O que a Jaguar Animal Health (JAGX) comunicou ao mercado, do mais recente para o mais antigo.
- LULD halt | JAGXFato relevante
- LULD halt | JAGXFato relevante
- LULD halt | JAGXFato relevante
Principais indicadores financeiros
Resultados divulgados pela Jaguar Animal Health, em USD.
- Cap. de mercado
- 4,9 mi
- Receita (TTM)
- 27,8 mi
- P/L
- —
- LPA (diluído, TTM)
- -4012.7
- Dividend yield
- —
- Margem de lucro
- -130.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 11,5 mi | -45,1 mi | -53,4 mi | |
| 11,7 mi | -30,8 mi | -38,5 mi | |
| 9,8 mi | -34,3 mi | -41,3 mi | |
| 12 mi | -34,4 mi | -47,5 mi |